Orbimed Advisors - GRAPHITE BIO INC ownership

GRAPHITE BIO INC's ticker is GRPH and the CUSIP is 38870X104. A total of 62 filers reported holding GRAPHITE BIO INC in Q2 2022. The put-call ratio across all filers is 1.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of GRAPHITE BIO INC
ValueSharesWeighting
Q3 2022$2,689,000
+15.3%
848,4120.0%0.05%
+19.0%
Q2 2022$2,333,000
-70.8%
848,412
-45.8%
0.04%
-67.4%
Q1 2022$7,986,000
-59.0%
1,565,8120.0%0.13%
-48.4%
Q4 2021$19,463,000
-18.1%
1,565,812
+8.0%
0.25%
-4.2%
Q3 2021$23,764,000
-30.1%
1,449,904
+31.1%
0.26%
-24.1%
Q2 2021$33,997,0001,106,3070.34%
Other shareholders
GRAPHITE BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 8,459,314$26,816,0006.25%
Privium Fund Management (UK) Ltd 564,946$1,791,0002.28%
OUP Management Co., LLC 406,308$1,288,0002.01%
Opaleye Management Inc. 577,250$1,830,0000.76%
Prosight Management, LP 356,445$1,130,0000.60%
TANG CAPITAL MANAGEMENT LLC 1,100,000$3,487,0000.43%
EcoR1 Capital, LLC 1,582,135$5,015,0000.15%
Board of Trustees of The Leland Stanford Junior University 703,071$2,229,0000.14%
Oasis Management Co Ltd. 255,102$809,0000.14%
Avidity Partners Management LP 1,575,000$4,993,0000.10%
View complete list of GRAPHITE BIO INC shareholders